Cargando…

Conformational characterization of a novel anti-HER2 candidate antibody

Regulatory agencies establish that a broad physicochemical and biological characterization is necessary for the evaluation of comparability between a biosimilar candidate product and a reference commercial drug. Between them, conformational characterization of proteins is of vital importance to dete...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moro Pérez, Leina, Rodríguez Taño, Azalia de la Caridad, Martín Márquez, Lázaro Roberto, Gómez Pérez, Jose Alberto, Valle Garay, Aisel, Blanco Santana, Rancés
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6508720/ https://www.ncbi.nlm.nih.gov/pubmed/31071101 http://dx.doi.org/10.1371/journal.pone.0215442

Ejemplares similares

Conformational characterization of the mammalian-expressed SARS-CoV-2 recombinant receptor binding domain, a COVID-19 vaccine
por: Moro-Pérez, Leina, et al.
Publicado: (2023)

Validation of a Flow Cytometry Based Binding Assay for Evaluation of Monoclonal Antibody Recognizing EGF Receptor
por: Cedeño-Arias, Mercedes, et al.
Publicado: (2011)

Frequent co-expression of EGFR and NeuGcGM3 ganglioside in cancer: it’s potential therapeutic implications
por: Palomo, Addys González, et al.
Publicado: (2016)

HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates
por: Ocaña, Alberto, et al.
Publicado: (2020)

Extensive conformational and physical plasticity protects HER2-HER3 tumorigenic signaling
por: Campbell, Marcia R., et al.
Publicado: (2022)

Extensive conformational and physical plasticity protects HER2-HER3 tumorigenic signaling
por: Campbell, Marcia R., et al.
Publicado: (2022)

Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies
por: Bergado-Báez, Gretchen, et al.
Publicado: (2022)

Role of BamHI-A Rightward Frame 1 in Epstein–Barr Virus-Associated Epithelial Malignancies
por: Blanco, Rancés, et al.
Publicado: (2020)

Immunohistochemical Characterization of Three Monoclonal Antibodies Raised against the Epidermal Growth Factor and Its Receptor in Non-Small-Cell Lung Cancer: Their Potential Use in the Selection of Patients for Immunotherapy
por: Rengifo, Charles E., et al.
Publicado: (2013)

Domain-level epitope mapping of polyclonal antibodies against HER-1 and HER-2 receptors using phage display technology
por: Pérez-Martínez, Dayana, et al.
Publicado: (2022)

Immunohistochemical Reactivity of the 14F7 Monoclonal Antibody Raised against N-Glycolyl GM3 Ganglioside in Some Benign and Malignant Skin Neoplasms
por: Blanco, Rancés, et al.
Publicado: (2011)

HER3 targeting with an antibody‐drug conjugate bypasses resistance to anti‐HER2 therapies
por: Gandullo‐Sánchez, Lucía, et al.
Publicado: (2020)

Structural and biochemical analysis reveals how ferulic acid improves catalytic efficiency of Humicola grisea xylanase
por: Oliveira, Izadora Cristina Moreira, et al.
Publicado: (2022)

Theoretical study of large conformational transitions in DNA: the B↔A conformational change in water and ethanol/water
por: Noy, Agnes, et al.
Publicado: (2007)

Anti-proliferative and pro-apoptotic effects induced by simultaneous inactivation of HER1 and HER2 through endogenous polyclonal antibodies
por: Suárez, Narjara González, et al.
Publicado: (2017)

Binding Affinity of Trastuzumab and Pertuzumab Monoclonal Antibodies to Extracellular HER2 Domain †
por: Cruz, Victor L., et al.
Publicado: (2023)

Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates
por: Albarrán, Víctor, et al.
Publicado: (2022)

Nucleotides Entrapped in Liposome Nanovesicles as Tools for Therapeutic and Diagnostic Use in Biomedical Applications
por: Cardador, Camila Magalhães, et al.
Publicado: (2023)

Exploring polymorphisms in B-DNA helical conformations
por: Dans, Pablo D., et al.
Publicado: (2012)

Carvacrol: An In Silico Approach of a Candidate Drug on HER2, PI3Kα, mTOR, hER-α, PR, and EGFR Receptors in the Breast Cancer
por: Herrera-Calderon, Oscar, et al.
Publicado: (2020)

Conformation-controlled binding kinetics of antibodies
por: Galanti, Marta, et al.
Publicado: (2016)

Conformational Ensembles of Antibodies Determine Their Hydrophobicity
por: Waibl, Franz, et al.
Publicado: (2021)

Peptidomimetic-based antibody surrogate for HER2
por: Zheng, Mengmeng, et al.
Publicado: (2021)

Determination of Conformational and Functional Stability of Potential Plague Vaccine Candidate in Formulation
por: Athirathinam, Krubha, et al.
Publicado: (2022)

Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer
por: Norton, Nadine, et al.
Publicado: (2018)

Prevention and Therapy of Metastatic HER-2(+) Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine
por: Ruzzi, Francesca, et al.
Publicado: (2022)

Deletion of Vaccinia Virus A40R Gene Improves the Immunogenicity of the HIV-1 Vaccine Candidate MVA-B
por: Pérez, Patricia, et al.
Publicado: (2020)

Correlation of HER2/neu antibody response to clinical response in a Phase II trial of the ae37+gm-csf her2 peptide vaccine
por: Greene, Julia, et al.
Publicado: (2014)

Aberrant expression of N-glycolyl GM3 ganglioside is associated with the aggressive biological behavior of human sarcomas
por: Pilco-Janeta, Daniel, et al.
Publicado: (2019)

Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer
por: Schneeweiss, Andreas, et al.
Publicado: (2018)

High-Risk Human Papillomavirus and Epstein–Barr Virus Coinfection: A Potential Role in Head and Neck Carcinogenesis
por: Blanco, Rancés, et al.
Publicado: (2021)

Epstein–Barr Virus Association with Breast Cancer: Evidence and Perspectives
por: Arias-Calvachi, Claudia, et al.
Publicado: (2022)

AFCo1, a meningococcal B-derived cochleate adjuvant, strongly enhances antibody and T-cell immunity against Plasmodium falciparum merozoite surface protein 4 and 5
por: Bracho, Gustavo, et al.
Publicado: (2009)

Stability Enhancement of a Dimeric HER2-Specific Affibody Molecule through Sortase A-Catalyzed Head-to-Tail Cyclization
por: Westerlund, Kristina, et al.
Publicado: (2021)

An experimental approach probing the conformational transitions and energy landscape of antibodies: a glimmer of hope for reviving lost therapeutic candidates using ionic liquid
por: Shmool, Talia A., et al.
Publicado: (2021)

Dissecting Antibodies with Regards to Linear and Conformational Epitopes
por: Forsström, Björn, et al.
Publicado: (2015)

HER2 expression in cervical cancer as a potential therapeutic target
por: Chavez-Blanco, Alma, et al.
Publicado: (2004)

Current Hepatitis C Vaccine Candidates Based on the Induction of Neutralizing Antibodies
por: Gomez-Escobar, Elsa, et al.
Publicado: (2023)

High-Risk Human Papillomavirus and Tobacco Smoke Interactions in Epithelial Carcinogenesis
por: Aguayo, Francisco, et al.
Publicado: (2020)

HER4 in breast cancer: comparison of antibodies against intra- and extra-cellular domains of HER4
por: Tovey, Sian M, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_1dbpepfctee6jg6bhd9c0hjmgv